Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.

[1] In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.

[2]

This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.